Jinsy Andrews - Concepedia

Author

Jinsy Andrews

Also Known As

Andrews, Jinsy, Francesco Alessandrini, Ikjae Lee, J. A. Andrews, J. Andrews, Jinsy A Andrews, Jinsy A. Andrews, Jinsy Andrews, Megan Grosso, Patricia Andres

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Columbia University The Neurological Institute Cytokinetics (United States)Barrow Neurological Institute Massachusetts General Hospital

About

Jinsy Andrews is an author at Columbia University specializing in neurodegenerative diseases, neurology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	111
2	Neurology	3	3	111
3	Public Health	1	1	33
4	Biostatistics	1	1	33
5	Genomic Medicine	1	1	45

Jinsy Andrews

Publications

Citations

H-Index

Page 1

	Year	Citations
Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study Michael Benatar, Joanne Wuu, Peter M. Andersen, Neurotherapeutics	2022	156
Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis Jinsy Andrews, Carlayne E. Jackson, Terry Heiman‐Patterson, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration	2020	143
Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis Jinsy Andrews, Lisa Meng, Sarah Kulke, JAMA Neurology	2017	84
Respiratory measures in amyotrophic lateral sclerosis Noah Lechtzin, Merit Cudkowicz, Mamede de Carvalho, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration	2018	70
CK‐2127107 amplifies skeletal muscle response to nerve activation in humans Jinsy Andrews, Vipin Vijayakumar, R Stoltz, Muscle & Nerve	2017	66
Amyotrophic lateral sclerosis care and research in the United States during the <scp>COVID</scp>‐19 pandemic: Challenges and opportunities Jinsy Andrews, James D. Berry, Robert H. Baloh, Muscle & Nerve	2020	58
Experience with the Awaji Island modifications to the ALS diagnostic criteria Amy Chen, Louis H. Weimer, Thomas H. Brannagan, Muscle & Nerve	2010	48
The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis Kristiana Salmon, Matthew C. Kiernan, Seung Hyun Kim, Brain Neurodegenerative DiseasesGenetic TestingEarly Genetic TestingSporadic AlsSeveral Genetically-targeted Therapies	2021	45
A phase III trial of <i>tirasemtiv</i> as a potential treatment for amyotrophic lateral sclerosis Jeremy M. Shefner, Merit Cudkowicz, Orla Hardiman, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration	2019	44
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study Stacy A. Rudnicki, Jinsy Andrews, Tina Duong, Neurotherapeutics	2021	43

Page 1